🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/02/2019 | 115,52 | 116,25 | 114,55 | 115,83 | +0,43% | 1,47% | 273.100 |
| 31/01/2019 | 115,97 | 115,97 | 114,45 | 115,33 | -0,68% | 1,31% | 302.600 |
| 30/01/2019 | 116,16 | 116,69 | 114,26 | 116,12 | +0,04% | 2,09% | 236.100 |
| 29/01/2019 | 116,53 | 116,70 | 114,80 | 116,07 | -0,22% | 1,63% | 265.800 |
| 28/01/2019 | 115,20 | 116,49 | 113,66 | 116,33 | +0,35% | 2,46% | 420.300 |
| 25/01/2019 | 114,58 | 116,13 | 111,01 | 115,93 | +1,43% | 4,47% | 346.600 |
| 24/01/2019 | 114,60 | 115,45 | 112,53 | 114,30 | -0,28% | 2,55% | 215.100 |
| 23/01/2019 | 114,18 | 115,08 | 110,51 | 114,62 | +0,63% | 4,00% | 473.800 |
| 22/01/2019 | 115,15 | 115,15 | 112,25 | 113,90 | -1,60% | 2,52% | 389.000 |
| 18/01/2019 | 115,02 | 115,82 | 114,29 | 115,75 | +1,37% | 1,33% | 290.500 |
| 17/01/2019 | 113,04 | 114,96 | 112,27 | 114,19 | +0,50% | 2,38% | 284.700 |
| 16/01/2019 | 115,13 | 116,23 | 112,72 | 113,62 | -1,16% | 3,05% | 311.200 |
| 15/01/2019 | 114,73 | 115,95 | 113,34 | 114,95 | +0,83% | 2,27% | 286.300 |
| 14/01/2019 | 114,36 | 115,92 | 113,60 | 114,00 | -0,75% | 2,03% | 400.300 |
| 11/01/2019 | 114,17 | 115,74 | 113,45 | 114,86 | +0,51% | 2,01% | 166.100 |
| 10/01/2019 | 113,00 | 114,65 | 111,47 | 114,28 | +0,68% | 2,81% | 316.700 |
| 09/01/2019 | 113,87 | 114,31 | 112,04 | 113,51 | +0,13% | 1,99% | 249.500 |
| 08/01/2019 | 114,89 | 114,89 | 111,74 | 113,36 | -0,44% | 2,74% | 368.400 |
| 07/01/2019 | 112,67 | 114,93 | 110,66 | 113,86 | +1,39% | 3,79% | 331.400 |
| 04/01/2019 | 108,43 | 112,66 | 108,43 | 112,30 | +4,81% | 3,90% | 590.600 |
| 03/01/2019 | 107,88 | 108,61 | 105,88 | 107,15 | -0,46% | 2,53% | 351.500 |
| 02/01/2019 | 107,85 | 109,63 | 106,58 | 107,65 | -1,15% | 2,83% | 518.200 |
| 31/12/2018 | 105,68 | 108,91 | 105,68 | 108,90 | +3,67% | 3,06% | 373.300 |
| 28/12/2018 | 105,50 | 107,29 | 104,00 | 105,04 | -0,25% | 3,12% | 309.300 |
| 27/12/2018 | 104,12 | 105,33 | 101,76 | 105,30 | -0,52% | 3,43% | 300.800 |
| 26/12/2018 | 101,55 | 106,04 | 101,55 | 105,85 | +4,39% | 4,42% | 327.100 |
| 24/12/2018 | 101,99 | 103,12 | 100,06 | 101,40 | -1,08% | 3,00% | 192.100 |
| 21/12/2018 | 103,56 | 106,13 | 100,60 | 102,51 | -0,51% | 5,34% | 1.096.600 |
| 20/12/2018 | 104,38 | 105,56 | 102,19 | 103,04 | -1,08% | 3,23% | 491.500 |
| 19/12/2018 | 105,57 | 107,72 | 102,27 | 104,17 | -1,82% | 5,16% | 356.700 |